XML 54 R43.htm IDEA: XBRL DOCUMENT
v3.24.3

Note 15 - (Loss) Earnings Per Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Notes Tables |
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] |
(in thousands, except per share data) |  | Three months ended September 30, |  |  | Nine months ended September 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(Loss) income from continuing operations |  | $ | (2,176 | ) |  | $ | (797 | ) |  | $ | (6,644 | ) |  | $ | 25,158 |
Less: net income from continuing operations attributable to noncontrolling interests |  |  | (491 | ) |  |  | (351 | ) |  |  | (825 | ) |  |  | (121 | )
Less: dividends on preferred stock |  |  | (13 | ) |  |  | — |  |  |  | (13 | ) |  |  | (74 | )
Numerator used in calculating basic (loss) earnings per share from continuing operations attributable to common shareholders |  | $ | (2,680 | ) |  | $ | (1,148 | ) |  | $ | (7,482 | ) |  | $ | 24,963 |
Adjustment to add-back dividends on preferred stock |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 74 |
Adjustment for proportionate interest in Ravix and SNS earnings attributable to common stock |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (77 | )
Numerator used in calculating diluted (loss) earnings per share from continuing operations attributable to common shareholders |  | $ | (2,680 | ) |  | $ | (1,148 | ) |  | $ | (7,482 | ) |  | $ | 24,960 |
(Loss) income from discontinued operations |  |  | (135 | ) |  |  | 122 |  |  |  | (181 | ) |  |  | 339 |
Numerator used in calculating diluted (loss) earnings per share - net (loss) income attributable to common shareholders |  | $ | (2,815 | ) |  | $ | (1,026 | ) |  | $ | (7,663 | ) |  | $ | 25,299 |
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-average basic shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-average common shares outstanding |  |  | 27,197 |  |  |  | 26,239 |  |  |  | 27,213 |  |  |  | 25,206 |
Weighted-average diluted shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-average common shares outstanding |  |  | 27,197 |  |  |  | 26,239 |  |  |  | 27,213 |  |  |  | 25,206 |
Effect of potentially dilutive securities (a) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Unvested restricted stock awards |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 735 |
Convertible preferred stock |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Total weighted-average diluted shares |  |  | 27,197 |  |  |  | 26,239 |  |  |  | 27,213 |  |  |  | 25,941 |
Basic (loss) earnings attributable to common shareholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Continuing operations |  | $ | (0.10 | ) |  | $ | (0.04 | ) |  | $ | (0.27 | ) |  | $ | 0.99 |
Discontinued operations |  | $ | — |  |  | $ | 0.00 |  |  | $ | (0.01 | ) |  | $ | 0.01 |
Basic (loss) earnings per share - net (loss) income attributable to common shareholders: |  | $ | (0.10 | ) |  | $ | (0.04 | ) |  | $ | (0.28 | ) |  | $ | 1.00 |
Diluted (loss) earnings attributable to common shareholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Continuing operations |  | $ | (0.10 | ) |  | $ | (0.04 | ) |  | $ | (0.27 | ) |  | $ | 0.96 |
Discontinued operations |  | $ | — |  |  | $ | 0.00 |  |  | $ | (0.01 | ) |  | $ | 0.01 |
Diluted (loss) earnings per share - net (loss) income attributable to common shareholders |  | $ | (0.10 | ) |  | $ | (0.04 | ) |  | $ | (0.28 | ) |  | $ | 0.97 |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] |
|  | Three months ended September 30, |  |  | Nine months ended September 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Stock options |  |  | 265,000 |  |  |  | — |  |  |  | 265,000 |  |  |  | — |
Unvested restricted stock awards |  |  | 448,964 |  |  |  | 1,046,947 |  |  |  | 448,964 |  |  |  | — |
Convertible preferred stock |  |  | 868,421 |  |  |  | — |  |  |  | 868,421 |  |  |  | — |
Total |  |  | 1,582,385 |  |  |  | 1,046,947 |  |  |  | 1,582,385 |  |  |  | — |

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration